Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi
Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi
Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Effects</strong> <strong>of</strong> treatment on sk<strong>in</strong> barrier function .............................................................. 33�<br />
Sk<strong>in</strong> atrophy and collagen synthesis <strong>of</strong> the sk<strong>in</strong> ......................................................... 33�<br />
<strong>Effects</strong> <strong>of</strong> glucocorticosteroids on sk<strong>in</strong> collagen synthesis......................................... 34�<br />
<strong>Effects</strong> <strong>of</strong> AD treatment on sk<strong>in</strong> <strong>in</strong>fections................................................................. 37�<br />
AIMS OF THE STUDY............................................................................................................ 38�<br />
SUBJECTS AND METHODS.................................................................................................. 39�<br />
Study designs ..................................................................................................................... 39�<br />
Subjects .............................................................................................................................. 39�<br />
Inclusion criteria ......................................................................................................... 40�<br />
Exclusion criteria ........................................................................................................ 40�<br />
Methods.............................................................................................................................. 42�<br />
Treatment with <strong>tacrolimus</strong> o<strong>in</strong>tment........................................................................... 42�<br />
Assessment <strong>of</strong> <strong>atopic</strong> <strong>dermatitis</strong> ................................................................................. 42�<br />
Staphylococcus aureus colonization ........................................................................... 43�<br />
Sk<strong>in</strong> collagen synthesis and sk<strong>in</strong> thickness................................................................. 43�<br />
Respiratory symptoms and f<strong>in</strong>d<strong>in</strong>gs ........................................................................... 44�<br />
Lung function tests ............................................................................................. 44�<br />
Questionnaire...................................................................................................... 44�<br />
Induced sputum .................................................................................................. 44�<br />
Sk<strong>in</strong> prick tests and serum IgE ........................................................................... 45�<br />
Conjunctival cytology................................................................................................. 45�<br />
Statistical methods...................................................................................................... 46�<br />
RESULTS................................................................................................................................... 47�<br />
Cl<strong>in</strong>ical ef<strong>fi</strong>cacy and safety............................................................................................... 47�<br />
Staphylococcus aureus colonization ................................................................................ 48�<br />
Sk<strong>in</strong> collagen synthesis and sk<strong>in</strong> thickness ..................................................................... 48�<br />
Conjunctival cytology ....................................................................................................... 49�<br />
Respiratory symptoms and f<strong>in</strong>d<strong>in</strong>gs................................................................................ 49�<br />
Respiratory symptoms ................................................................................................ 50�<br />
Bronchial hyper-responsiveness ................................................................................. 50�<br />
Induced sputum........................................................................................................... 51�<br />
Sk<strong>in</strong> prick tests and serum IgE ................................................................................... 52�<br />
Patients on <strong>in</strong>haled corticosteroids.................................................................................. 53�<br />
DISCUSSION ............................................................................................................................ 55�<br />
ACKNOWLEDGEMENTS...................................................................................................... 62�<br />
REFERENCES.......................................................................................................................... 64�<br />
Appendix: ORIGINAL PUBLICATIONS